KYMR FY 2019 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

KYMRKymera Therapeutics, Inc.

$7B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M

Gross Profit

$2M71.9% margin

Operating Income

-$42M-1438.5% margin

Net Income

-$41M-1407.4% margin

EPS (Diluted)

$-0.93

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$117M

Total Liabilities

$191M

Stockholders' Equity

-$74M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$0	—
Gross Profit	$2M	-$205,000	+1128.8%
Operating Income	-$42M	-$21M	-96.8%
Net Income	-$41M	-$21M	-92.4%